DK1071704T3 - Nye matrix metalloproteinasehæmmere og nedregulatorer - Google Patents

Nye matrix metalloproteinasehæmmere og nedregulatorer

Info

Publication number
DK1071704T3
DK1071704T3 DK99910394T DK99910394T DK1071704T3 DK 1071704 T3 DK1071704 T3 DK 1071704T3 DK 99910394 T DK99910394 T DK 99910394T DK 99910394 T DK99910394 T DK 99910394T DK 1071704 T3 DK1071704 T3 DK 1071704T3
Authority
DK
Denmark
Prior art keywords
inhibitors
regulators
mmp
matrix metalloproteinase
novel
Prior art date
Application number
DK99910394T
Other languages
Danish (da)
English (en)
Inventor
Erkki Koivunen
Timo Sorsa
Tuula Salo
Original Assignee
Ctt Cancer Targeting Tech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctt Cancer Targeting Tech Oy filed Critical Ctt Cancer Targeting Tech Oy
Application granted granted Critical
Publication of DK1071704T3 publication Critical patent/DK1071704T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99910394T 1998-03-18 1999-03-17 Nye matrix metalloproteinasehæmmere og nedregulatorer DK1071704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980604A FI980604A0 (fi) 1998-03-18 1998-03-18 Nya matrismetalloproteinasinhibitorer och -regulatorer
PCT/FI1999/000204 WO1999047550A1 (en) 1998-03-18 1999-03-17 Novel matrix metalloproteinase inhibitors and down-regulators

Publications (1)

Publication Number Publication Date
DK1071704T3 true DK1071704T3 (da) 2003-10-20

Family

ID=8551311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910394T DK1071704T3 (da) 1998-03-18 1999-03-17 Nye matrix metalloproteinasehæmmere og nedregulatorer

Country Status (12)

Country Link
US (1) US6624144B1 (ja)
EP (1) EP1071704B1 (ja)
JP (1) JP2002506881A (ja)
AT (1) ATE243709T1 (ja)
AU (1) AU2936599A (ja)
CA (1) CA2323239C (ja)
DE (1) DE69909076T2 (ja)
DK (1) DK1071704T3 (ja)
ES (1) ES2203088T3 (ja)
FI (1) FI980604A0 (ja)
PT (1) PT1071704E (ja)
WO (1) WO1999047550A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907908D0 (en) * 1999-04-07 1999-06-02 Bataille Regis Organic compounds
DE10020447A1 (de) * 2000-03-31 2001-10-11 Henkel Kgaa Verwendung von Protease-Inhibitoren in der Kosmetik und Pharmazie
EP1174129A1 (en) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Use of a matrix-metalloprotease inhibitor for the treatment of cancer
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
FI113840B (fi) * 2001-03-26 2004-06-30 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
AU2002357370A1 (en) * 2001-12-20 2003-07-09 Hartmut M. Hanauske-Abel Treatment for averting or delaying premature delivery
BR0307155A (pt) * 2002-01-08 2007-06-19 Michael R Raab plantas transgênicas expressando proteìnas modificadas por civps ou inteìnas e método relativo
US20040224378A1 (en) * 2002-06-07 2004-11-11 Athersys, Inc. Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifs
FI20021726A0 (fi) * 2002-09-27 2002-09-27 Ctt Cancer Targeting Tech Oy Menetelmä peptidien tuottamiseksi
CN1314704C (zh) * 2002-11-20 2007-05-09 中国人民解放军军事医学科学院放射与辐射医学研究所 基质金属蛋白酶2的小肽抑制剂
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
ES2537514T3 (es) 2003-04-04 2015-06-09 Incyte Corporation Composiciones, métodos y kits relacionados con la escisión de HER-2
US7371364B2 (en) 2003-08-15 2008-05-13 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
FR2932182A1 (fr) * 2008-06-10 2009-12-11 Commissariat Energie Atomique Cyclopeptides utilisables en tant qu'inhibiteurs d'enzymes proteases du type mmp
KR101363455B1 (ko) 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도
CN108484729B (zh) * 2018-03-23 2019-09-17 中国药科大学 一种基质金属蛋白酶9的多肽抑制剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666897A (en) 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
AU695796B2 (en) 1994-10-05 1998-08-20 Darwin Discovery Limited Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
US5652227A (en) 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals

Also Published As

Publication number Publication date
US6624144B1 (en) 2003-09-23
FI980604A0 (fi) 1998-03-18
PT1071704E (pt) 2003-11-28
JP2002506881A (ja) 2002-03-05
EP1071704B1 (en) 2003-06-25
EP1071704A1 (en) 2001-01-31
AU2936599A (en) 1999-10-11
DE69909076T2 (de) 2004-05-06
WO1999047550A1 (en) 1999-09-23
CA2323239C (en) 2008-04-15
ES2203088T3 (es) 2004-04-01
ATE243709T1 (de) 2003-07-15
CA2323239A1 (en) 1999-09-23
DE69909076D1 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
DK1071704T3 (da) Nye matrix metalloproteinasehæmmere og nedregulatorer
DE69433647D1 (de) Menschliche proteaseinhibitoren vom kunitztyp
PT1261600E (pt) Derivados heteroaromaticos de carboxamida e sua utilizacao como inibidores do enzima ikk-2
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
UY27972A1 (es) Derivados de hidantoína
NO972538L (no) Nye sulfonamider
ES2193949T3 (es) Nuevos derivados del acido lipoico, su preparacion y composiciones farmaceuticas que los contienen.
MXPA04010555A (es) Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
NO306614B1 (no) Derivater i vitamin D-serien modifisert ved 20-stilling, mellomprodukter anvendt ved fremstilling av disse, farmasöytiske preparater inneholdende derivatene og deres anvendelse ved fremstilling av legemidler
JP2000226329A (ja) Ｍｍｐ阻害剤
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
NO20000784L (no) Nye aggrecanaseinhibitorer og matriksmetalloproteinaser for behandling av artritt
BR0109780A (pt) Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
BR0315820A (pt) Inibidores de integrase de hiv, composições farmacêuticas e métodos para a sua utilização
SE9903894D0 (sv) Novel compounds
HUP0300972A2 (hu) Gatifloxacin-pentahidrát
ATE253359T1 (de) Antithrombotische mittel
Sandya et al. Multiple matrix metalloproteinases in type II collagen induced arthritis
ATE225170T1 (de) Inhibitoren der metazoenparasiten-proteasen
BRPI0415885A (pt) ácidos piperidinil-e piperazinil-sulfonilmetilidroxámicos e sua utilização como inibidores de protease
ATE286395T1 (de) Antithrombotische mittel
NO20032314L (no) Nye desloratadinsalter, fremgangsmåte for deres syntese og farmasöytiske preparater derav
PT1246790E (pt) Bases de mannich de 1- e 2-naftol substituido